GALECTIN THERAPEUTICS INC (GALT) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 640 transactions totaling $75.7M, demonstrating a bullish sentiment with $7.8M in net insider flow. The most recent transaction on Jan 16, 2026 involved a transaction of 60,000 shares valued at $0.
No significant insider buying has been recorded for GALT in the recent period.
No significant insider selling has been recorded for GALT in the recent period.
Based on recent SEC filings, insider sentiment for GALT is bullish with an Insider Alignment Score of 55/100 and a net flow of $7.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at GALECTIN THERAPEUTICS INC (GALT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading GALT stock, having executed 640 transactions in the past 90 days. The most active insider is Richard E. Uihlein (Executive), who has made 28 transactions totaling $56.3M.
Get notified when executives and directors at GALT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | Carson Benjamin Sr | Executive | Award | 60,000 | $N/A | $0 | |
| Jan 16, 2026 | E. Uihlein Richard | Executive | Award | 60,000 | $N/A | $0 | |
| Jan 16, 2026 | E. Uihlein Richard | Executive | Award | 13,158 | $3.04 | $40.0K | |
| Jan 16, 2026 | J. Schwartz Elissa | Executive | Award | 60,000 | $N/A | $0 | |
| Jan 16, 2026 | F. Amelio Gilbert | Executive | Award | 60,000 | $N/A | $0 | |
| Jan 16, 2026 | S. Omenn Gilbert | Executive | Award | 60,000 | $N/A | $0 | |
| Jan 16, 2026 | H. Shlevin Harold | Executive | Award | 60,000 | $N/A | $0 | |
| Jan 5, 2026 | Lewis Joel | Executive | Purchase | 56,332 | $3.88 | $218.6K | |
| Dec 31, 2025 | Jamil Khurram | Chief Medical Officer | Option Exercise | 8,125 | $N/A | $0 | |
| Dec 31, 2025 | Jamil Khurram | Chief Medical Officer | Sale | 8,125 | $4.07 | $33.1K | |
| Dec 31, 2025 | Jamil Khurram | Chief Medical Officer | Option Exercise | 8,125 | $1.23 | $10.0K | |
| Dec 23, 2025 | Eldred Kary | Executive | Purchase | 700 | $3.73 | $2.6K | |
| Dec 23, 2025 | D. Freeman Kevin | Executive | Purchase | 5,500 | $3.55 | $19.5K | |
| Dec 23, 2025 | Eldred Kary | Executive | Purchase | 700 | $3.73 | $2.6K | |
| Dec 23, 2025 | D. Freeman Kevin | Executive | Purchase | 5,500 | $3.55 | $19.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 118 | $42.0M | 28.9% |
Sale(S) | 170 | $34.0M | 23.4% |
Exercise(M) | 132 | $28.6M | 19.7% |
Exercise (Options)(X) | 7 | $18.5M | 12.8% |
Other(J) | 66 | $9.5M | 6.6% |
Conversion(C) | 4 | $8.5M | 5.9% |
Award(A) | 124 | $2.7M | 1.8% |
Payment(F) | 8 | $1.2M | 0.9% |
Gift(G) | 7 | $34.6K | 0.0% |
Small Acquisition(L) | 1 | $5.1K | 0.0% |
Will Acquisition(W) | 1 | $0 | 0.0% |
Disposition(D) | 2 | $0 | 0.0% |
Insider activity at GALECTIN THERAPEUTICS INC shows mixed signals across all time. While $41.8M in purchases indicates some executive confidence,$34.0M in sales balances the picture, resulting in a modest net flow of $7.8M.25 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Richard E. Uihlein, has transacted $56.3M during this period.